China approves anti-tumor drug from Luye Pharma unit for treatment of cervical and ovarian cancer







Newswires MT 2022

All the news of LUYE PHARMA GROUP LTD.

Sales 2021 5,654 million
895 million
895 million
Net income 2021 836M
132 million
132 million
Net debt 2021 3,381 million
535 million
535 million
PER 2021 ratio 10.7x
2021 performance 1.58%
Capitalization 9,168M
1,451 million
1,451 million
EV / Sales 2021 2.22x
EV / Sales 2022 1.95x
# of employees 4,788
Floating 64.5%

Chart LUYE PHARMA GROUP LTD.


Duration :

Period :




Luye Pharma Group Ltd Technical Analysis Chart  |  MarketScreener

Trends in Technical Analysis LUYE PHARMA GROUP LTD.

Short term Middle term Long term
Tendencies Bearish Bearish Bearish



Evolution of the income statement

To sell

To buy

Medium consensus HOLD
Number of analysts 8
Last closing price

CNY2.59

Average target price

CNY3.95

Average Spread / Target 52.6%


Back To Top